Analysis of the degree of fibrosis in patients with steatotic liver disease associated with metabolic dysfunction (MASLD) using FibroScan®. Acervo Saúde [Internet]. 2026 Jan. 8 [cited 2026 Nov. 3];26(1):e22602. Available from: https://acervomais.com.br/saude/article/view/22602